Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2026-02-25 @ 8:49 PM
Study NCT ID:
NCT02270034
Status:
COMPLETED
Last Update Posted:
2022-03-10
First Post:
2014-10-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate Safety and Activity of Crizotinib With Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma
Sponsor:
Grupo Español de Investigación en Neurooncología
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-08-13
Start Date Type:
ACTUAL
Primary Completion Date:
2020-10-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-10-26
Completion Date Type:
ACTUAL
First Submit Date:
2014-10-14
First Submit QC Date:
None
Study First Post Date:
2014-10-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-09
Last Update Post Date:
2022-03-10
Last Update Post Date Type:
ACTUAL